Lanean...
Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
Modifying the entry of pyruvate into mitochondria may provide a unique approach to treat metabolic disease. The pharmacology of a new class of insulin sensitizers directed against a newly identified mitochondrial target may treat many aspects of nonalcoholic steatohepatitis, including fibrosis. This...
Gorde:
| Argitaratua izan da: | Hepatol Commun |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721453/ https://ncbi.nlm.nih.gov/pubmed/29404453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1036 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|